Skip to main content
Clinical Trials/IRCT20210302050549N1
IRCT20210302050549N1
Recruiting
Phase 2

A Study of the Effect of Intravenous Infusion of Magnesium Sulfate on the Level of Intraoperative End-Tidal CO2 and Postoperative Pain in Laparoscopic Cholecystectomy

Rafsanjan University of Medical Sciences0 sites62 target enrollmentTBD
ConditionsEnd-Tidal CO2.

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
End-Tidal CO2.
Sponsor
Rafsanjan University of Medical Sciences
Enrollment
62
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA I\-II patients
  • 20 to 60 years of age

Exclusion Criteria

  • Drug allergy to magnesium sulfate
  • Any neuromuscular disease
  • (Ejection Fraction)EF \< 40%
  • Hypotension or Bradycardia by more than 20% during anesthesia
  • Cardiac disease
  • Hepatic or Renal failure
  • Chronic respiratory failure
  • Morbid obesity

Outcomes

Primary Outcomes

Not specified

Similar Trials